Akzo Nobel Escapes $421M Medicaid Kickback Suit

Law360, New York (April 3, 2012, 3:57 PM EDT) -- A federal judge agreed on Friday to dismiss a False Claims Act case filed by employee whistleblowers against Akzo Nobel NV, the former parent of Organon USA Inc., a pharmaceutical company accused of operating a kickback scheme that helped overcharge Medicaid by $421 million.

While U.S. District Judge Rya W. Zobel of Massachusetts federal court dismissed the claims against Akzo Nobel for lack of jurisdiction, the claims against several other defendants, including Organon, Merck & Co. Inc. and Schering Plough Corp., are still pending.

Organon and...
To view the full article, register now.




Case Information

Case Title

United States of America et al v. Organon USA Inc et al

Case Number




Nature of Suit

Other Statutory Actions


Rya W. Zobel

Date Filed

November 16, 2007

Law Firms


Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.